PRIMARY CARE OF THE
CHILDBEARING
CHAMBERLAIN UNIVERSITY FNP PROGRAM
NR 602 Pediatric Primary Care Midterm Study Guide & Test Bank
2026-2027 UPDATE EXAM
Comprehensive Coursework Alignment & Detailed Board-Style Rationales
Resource Title: Bright Futures Guidelines / i-Human Case Study: Katherine Harris
Subject: Advanced Pediatric Well-Child Supervision, Growth & Development, and Pulmonology
August 2026
,NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
NR 602 Pediatric Primary Care Midterm Test Bank (2026-2027 Updated
Edition)
EXAM BLUEPRINT & CURRICULUM MAPPING
This comprehensive study guide and test bank has been developed to prepare Family Nurse Practitioner (FNP)
students for the NR 602 Midterm Exam. All questions are rigorously grounded in the American Academy of
Pediatrics (AAP) Bright Futures Guidelines and the clinical i-Human Case Study of Katherine Harris (a 16-year-old
female presenting with an acute asthma exacerbation).
Curriculum Mapping & Weighting
Health Supervision & NP Roles (Questions 1, 41, 43): Distinguishing clinical scopes of Primary Care
Pediatric Nurse Practitioners and Acute Care Pediatric Nurse Practitioners; adolescent preventive services and
health supervision guidelines.
Asthma Pathophysiology & Clinical Signs (Questions 2-5, 9, 10, 25, 37, 39, 40): Airway inflam-
mation, bronchoconstriction, nocturnal asthma dips, accessory muscle retractions, objective hypoxia, wheezing
pathophysiology, resonance, and goblet cell hyperplasia.
Differential Diagnosis & Clinical Reasoning (Questions 6-8, 23, 26): Lead diagnoses, ruling out ”must-
not-miss” differentials (pneumonia, viral upper respiratory infections), bronchitis, reactive airway disease, and
atopic comorbidities.
Diagnostic Workup & Testing (Questions 11-15, 35, 42, 44): Spirometry parameters (FEV1, FVC,
FEV1/FVC), bronchodilator reversibility, peak flow meters, chest radiograph indications, and spacer device
optimization.
Clinical Pharmacology Care Plans (Questions 16-19, 20-22, 24, 30, 34, 38, 45): Daily inhaled
corticosteroid (ICS) controllers, quick-relief short-acting beta-agonists (SABA), SABA overuse risks, Asthma
Action Plan traffic-light zones, and exercise-induced bronchoconstriction (EIB) prophylaxis.
Test-Taking Strategies for Board Exams (AANP/ANCC)
1. Identify the Lead Diagnosis first: Analyze the patient’s subjective symptoms and objective vital signs to
prioritize the most likely diagnosis.
2. Look for Red Flags: Check for signs of respiratory distress (retractions, accessory muscle use, or hypoxia
SpO2 < 95%) that warrant immediate, acute intervention.
3. Differentiate Controller vs. Reliever: Understand the mechanism of action of daily preventative medications
(ICS) versus acute rescue bronchodilators (SABA) to answer pharmacological management questions.
Page 2 of 47
,NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
TOPIC: CHIEF COMPLAINT AND SUBJECTIVE DA T A CLINICAL REASONING
Question 1 of 45
A 16-year-old female, Katherine Harris, presents to the clinic with a 3-week history of dry cough and progressive
shortness of breath over the past 3 days. Which of the following details from her subjective history represents a
chronic predisposing risk factor belonging to the classic atopic triad?
A. Exposure to secondhand smoke in her apartment building.
B. A history of well-controlled childhood eczema.
C. Recent resolution of a mild upper respiratory infection.
D. Known household exposure to cockroaches.
ANSWER ✓: B — A history of well-controlled childhood eczema.
Explanation: Atopy is a genetic predisposition to develop allergic hypersensitivity reactions, classically manifested
as the ’atopic triad’: asthma, allergic rhinitis, and atopic dermatitis (eczema). The patient’s history of eczema
(Option B) is a key subjective finding that increases the clinical probability of reactive airway disease or asthma.
Environmental smoke (Option A) and cockroaches (Option D) are environmental triggers, and viral infections (Op-
tion C) are acute infectious triggers, but they are not genetic atopic predisposing factors themselves. TOPIC: KEY
FINDINGS ANAL YSIS AND INTERPRET A TION
Page 3 of 47
, NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
TOPIC: KEY FINDINGS ANAL YSIS AND INTERPRET A TION
Question 2 of 45
During the history taking, Katherine Harris reports that her shortness of breath is significantly worse at night. As
the FNP, how should you interpret this specific clinical finding in terms of asthma pathogenesis and severity?
A. Nighttime worsening is atypical for asthma and indicates a secondary cardiac etiology.
B. Nocturnal symptoms are common in asthma due to circadian fluctuations in cortisol, bronchomotor tone, and
airway inflammation.
C. It suggests that the patient has developed a panic disorder with nocturnal panic attacks.
D. It indicates a primary structural vocal cord dysfunction that worsens in the supine position.
ANSWER ✓: B — Nocturnal symptoms are common in asthma due to circadian fluctuations
in cortisol, bronchomotor tone, and airway inflammation.
Explanation: Nocturnal worsening of symptoms (’nocturnal asthma’) is a classic hallmark of asthma. It is driven
by diurnal varia- tions in physiological parameters, including a nighttime dip in circulating cortisol (an anti-
inflammatory hormone) and epinephrine (a bronchodilator), combined with increased vagal tone leading to bron-
choconstriction, and airway cooling. Option A is incorrect as it is highly typical of asthma. Options C and D rep-
resent alternative differentials but do not explain the physiologic nocturnal TOPIC: PHYSICAL EXAMINA TION
AND LABORED RESPIRA TIONS
Page 4 of 47
CHILDBEARING
CHAMBERLAIN UNIVERSITY FNP PROGRAM
NR 602 Pediatric Primary Care Midterm Study Guide & Test Bank
2026-2027 UPDATE EXAM
Comprehensive Coursework Alignment & Detailed Board-Style Rationales
Resource Title: Bright Futures Guidelines / i-Human Case Study: Katherine Harris
Subject: Advanced Pediatric Well-Child Supervision, Growth & Development, and Pulmonology
August 2026
,NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
NR 602 Pediatric Primary Care Midterm Test Bank (2026-2027 Updated
Edition)
EXAM BLUEPRINT & CURRICULUM MAPPING
This comprehensive study guide and test bank has been developed to prepare Family Nurse Practitioner (FNP)
students for the NR 602 Midterm Exam. All questions are rigorously grounded in the American Academy of
Pediatrics (AAP) Bright Futures Guidelines and the clinical i-Human Case Study of Katherine Harris (a 16-year-old
female presenting with an acute asthma exacerbation).
Curriculum Mapping & Weighting
Health Supervision & NP Roles (Questions 1, 41, 43): Distinguishing clinical scopes of Primary Care
Pediatric Nurse Practitioners and Acute Care Pediatric Nurse Practitioners; adolescent preventive services and
health supervision guidelines.
Asthma Pathophysiology & Clinical Signs (Questions 2-5, 9, 10, 25, 37, 39, 40): Airway inflam-
mation, bronchoconstriction, nocturnal asthma dips, accessory muscle retractions, objective hypoxia, wheezing
pathophysiology, resonance, and goblet cell hyperplasia.
Differential Diagnosis & Clinical Reasoning (Questions 6-8, 23, 26): Lead diagnoses, ruling out ”must-
not-miss” differentials (pneumonia, viral upper respiratory infections), bronchitis, reactive airway disease, and
atopic comorbidities.
Diagnostic Workup & Testing (Questions 11-15, 35, 42, 44): Spirometry parameters (FEV1, FVC,
FEV1/FVC), bronchodilator reversibility, peak flow meters, chest radiograph indications, and spacer device
optimization.
Clinical Pharmacology Care Plans (Questions 16-19, 20-22, 24, 30, 34, 38, 45): Daily inhaled
corticosteroid (ICS) controllers, quick-relief short-acting beta-agonists (SABA), SABA overuse risks, Asthma
Action Plan traffic-light zones, and exercise-induced bronchoconstriction (EIB) prophylaxis.
Test-Taking Strategies for Board Exams (AANP/ANCC)
1. Identify the Lead Diagnosis first: Analyze the patient’s subjective symptoms and objective vital signs to
prioritize the most likely diagnosis.
2. Look for Red Flags: Check for signs of respiratory distress (retractions, accessory muscle use, or hypoxia
SpO2 < 95%) that warrant immediate, acute intervention.
3. Differentiate Controller vs. Reliever: Understand the mechanism of action of daily preventative medications
(ICS) versus acute rescue bronchodilators (SABA) to answer pharmacological management questions.
Page 2 of 47
,NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
TOPIC: CHIEF COMPLAINT AND SUBJECTIVE DA T A CLINICAL REASONING
Question 1 of 45
A 16-year-old female, Katherine Harris, presents to the clinic with a 3-week history of dry cough and progressive
shortness of breath over the past 3 days. Which of the following details from her subjective history represents a
chronic predisposing risk factor belonging to the classic atopic triad?
A. Exposure to secondhand smoke in her apartment building.
B. A history of well-controlled childhood eczema.
C. Recent resolution of a mild upper respiratory infection.
D. Known household exposure to cockroaches.
ANSWER ✓: B — A history of well-controlled childhood eczema.
Explanation: Atopy is a genetic predisposition to develop allergic hypersensitivity reactions, classically manifested
as the ’atopic triad’: asthma, allergic rhinitis, and atopic dermatitis (eczema). The patient’s history of eczema
(Option B) is a key subjective finding that increases the clinical probability of reactive airway disease or asthma.
Environmental smoke (Option A) and cockroaches (Option D) are environmental triggers, and viral infections (Op-
tion C) are acute infectious triggers, but they are not genetic atopic predisposing factors themselves. TOPIC: KEY
FINDINGS ANAL YSIS AND INTERPRET A TION
Page 3 of 47
, NR 602 Pediatric Primary Care Midterm study guide & Test BankWeek
(2026-2027)
3 i-Human Case: Katherine Harris
TOPIC: KEY FINDINGS ANAL YSIS AND INTERPRET A TION
Question 2 of 45
During the history taking, Katherine Harris reports that her shortness of breath is significantly worse at night. As
the FNP, how should you interpret this specific clinical finding in terms of asthma pathogenesis and severity?
A. Nighttime worsening is atypical for asthma and indicates a secondary cardiac etiology.
B. Nocturnal symptoms are common in asthma due to circadian fluctuations in cortisol, bronchomotor tone, and
airway inflammation.
C. It suggests that the patient has developed a panic disorder with nocturnal panic attacks.
D. It indicates a primary structural vocal cord dysfunction that worsens in the supine position.
ANSWER ✓: B — Nocturnal symptoms are common in asthma due to circadian fluctuations
in cortisol, bronchomotor tone, and airway inflammation.
Explanation: Nocturnal worsening of symptoms (’nocturnal asthma’) is a classic hallmark of asthma. It is driven
by diurnal varia- tions in physiological parameters, including a nighttime dip in circulating cortisol (an anti-
inflammatory hormone) and epinephrine (a bronchodilator), combined with increased vagal tone leading to bron-
choconstriction, and airway cooling. Option A is incorrect as it is highly typical of asthma. Options C and D rep-
resent alternative differentials but do not explain the physiologic nocturnal TOPIC: PHYSICAL EXAMINA TION
AND LABORED RESPIRA TIONS
Page 4 of 47
